Dr. Herskowitz, President of ACAM, and Dr. Duncan Ross, PhD Immunology and founder and CEO of Kimera Labs, present a webinar where they discuss the anti-inflammatory and immunomodulatory properties of MSC exosomes. The discussion focuses on the cellular and molecular mechanisms of MSC exosomes and their effects on the immune system. They also touch on how these biological properties of MSC exosomes may be relevant to a variety of clinical conditions including COVID-19.
Learning Objectives:
1) Update on coronavirus in the USA;
2) The role of inflammatory cascades in viral illness;
3) Strategies to increase anti-inflammatory responses to COVID-19;
4) Specific regenerative medicine strategies to deal with serious COVID-19 infections.
